Satellos Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MSLE and other ETFs, options, and stocks.

About MSLE

Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. It operates through a proprietary technology platform, MyoReGenX™ and Leveraging MyoReGenX™, which identify stem cell based regeneration deficits in muscle diseases and develop therapeutic solutions. 

CEO
Frank Gleeson
CEOFrank Gleeson
Employees
18
Employees18
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
2012
Founded2012
Employees
18
Employees18

MSLE Key Statistics

Market cap
154.78M
Market cap154.78M
Price-Earnings ratio
-4.20
Price-Earnings ratio-4.20
Dividend yield
Dividend yield
Average volume
38.68K
Average volume38.68K
High today
High today
Low today
Low today
Open price
$7.52
Open price$7.52
Volume
0.00
Volume0.00
52 Week high
$13.39
52 Week high$13.39
52 Week low
$4.53
52 Week low$4.53

Stock Snapshot

As of today, Satellos Bioscience(MSLE) shares are valued at $7.26. The company's market cap stands at 154.78M, with a P/E ratio of -4.20.

During the trading day, Satellos Bioscience(MSLE) stock saw an opening price of $7.52, a peak of —, and a bottom of —.

Trading volume for Satellos Bioscience(MSLE) stock has reached 0, versus its average volume of 38.68K.

Over the past 52 weeks, Satellos Bioscience(MSLE) stock has traded between a high of $13.39 and a low of $4.53.

Over the past 52 weeks, Satellos Bioscience(MSLE) stock has traded between a high of $13.39 and a low of $4.53.

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MSLE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.